You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 13, 2024

CLINICAL TRIALS PROFILE FOR DORZAGLIATIN


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for Dorzagliatin

Trial ID Title Status Sponsor Phase Summary
NCT03790787 ↗ Drug Interaction Study Between Dorzagliatin and Empagliflozin Completed Hua Medicine Limited Phase 1 This is a Phase 1, open-label, sequential, multiple-dose, drug interaction study of glucokinase activator dorzagliatin and empagliflozin in subjects with T2DM. Pharmacokinetics and pharmacodynamics when dorzagliatin and empagliflozin given alone and in combination will be studied.
NCT03790839 ↗ Drug Interaction Study Between Dorzagliatin and Sitagliptin Completed Hua Medicine Limited Phase 1 This is a Phase 1, open-label, sequential, multiple-dose, drug interaction study of glucokinase activator dorzagliatin and sitagliptin in subjects with T2DM. Pharmacokinetics and pharmacodynamics when dorzagliatin and sitagliptin given alone and in combination will be studied.
NCT04080596 ↗ DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin Completed Hua Medicine Limited Phase 1 The purpose of this study is to investigate the impact of itraconzaole on the pharmacokinetics of Dorzagliatin.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Dorzagliatin

Condition Name

Condition Name
Intervention Trials
Drug Interaction 2
Patients 2
Diabetes Mellitus, Type 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH
Intervention Trials
Diabetes Mellitus, Type 2 2
Diabetes Mellitus 1
Glucose Intolerance 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Dorzagliatin

Trials by Country

Trials by Country
Location Trials
United States 2
China 2
Hong Kong 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State
Location Trials
New Jersey 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Dorzagliatin

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase Trials
Phase 3 1
Phase 2 1
Phase 1/Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase Trials
Completed 4
Not yet recruiting 2
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Dorzagliatin

Sponsor Name

Sponsor Name
Sponsor Trials
Hua Medicine Limited 4
Chinese University of Hong Kong 2
University of Virginia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type
Sponsor Trials
Industry 4
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.